Correlation Between Nexstim Oyj and Herantis Pharma

Can any of the company-specific risk be diversified away by investing in both Nexstim Oyj and Herantis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexstim Oyj and Herantis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nexstim Oyj and Herantis Pharma Oyj, you can compare the effects of market volatilities on Nexstim Oyj and Herantis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexstim Oyj with a short position of Herantis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexstim Oyj and Herantis Pharma.

Diversification Opportunities for Nexstim Oyj and Herantis Pharma

0.48

Correlation Coefficient

Nexstim Oyj  Herantis Pharma

Very weak diversification

The 3 months correlation between Nexstim and Herantis is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Nexstim Oyj and Herantis Pharma Oyj in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Herantis Pharma Oyj and Nexstim Oyj is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexstim Oyj are associated (or correlated) with Herantis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Herantis Pharma Oyj has no effect on the direction of Nexstim Oyj i.e., Nexstim Oyj and Herantis Pharma go up and down completely randomly.

Pair Corralation between Nexstim Oyj and Herantis Pharma

Assuming the 90 days trading horizon Nexstim Oyj is expected to generate 0.91 times more return on investment than Herantis Pharma. However, Nexstim Oyj is 1.1 times less risky than Herantis Pharma. It trades about 0.05 of its potential returns per unit of risk. Herantis Pharma Oyj is currently generating about 0.01 per unit of risk. If you would invest  414.00  in Nexstim Oyj on September 28, 2024 and sell it today you would earn a total of  400.00  from holding Nexstim Oyj or generate 96.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nexstim Oyj  vs.  Herantis Pharma Oyj

Nexstim Oyj

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nexstim Oyj are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent technical indicators, Nexstim Oyj demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Herantis Pharma Oyj

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Herantis Pharma Oyj are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent technical indicators, Herantis Pharma may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Nexstim Oyj and Herantis Pharma

The main advantage of trading using opposite Nexstim Oyj and Herantis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexstim Oyj position performs unexpectedly, Herantis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Herantis Pharma will offset losses from the drop in Herantis Pharma's long position.

The idea behind Nexstim Oyj and Herantis Pharma Oyj pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.